Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: a meta-analysis of randomized clinical trials

BACKGROUND AND AIM: Inotropes are commonly used to treat myocardial dysfunction, which is the major complication after coronary artery bypass graft (CABG). Milrinone, a phosphodiesterase 3 inhibitor, is one of these inotropes. Recently, a number of clinical studies have been carried out to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Zhigang, Huang, Lin, Cheng, Xiaoshu, Wu, Qinghua, Jiang, Xinghua, Wu, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699515/
https://www.ncbi.nlm.nih.gov/pubmed/26766900
http://dx.doi.org/10.2147/DDDT.S77464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699515/
https://www.ncbi.nlm.nih.gov/pubmed/26766900
http://dx.doi.org/10.2147/DDDT.S77464

Ejemplares similares